Ignite Creation Date:
2024-05-06 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 12:47 PM
Study NCT ID:
NCT03556228
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2018-04-29
Brief Title:
Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Sponsor:
Organization:
VM Oncology LLC